Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$6.47 - $8.96 $291,150 - $403,200
-45,000 Closed
0 $0
Q2 2019

Aug 16, 2019

SELL
$8.31 - $14.85 $53,184 - $95,040
-6,400 Reduced 12.45%
45,000 $419,000
Q1 2019

May 13, 2019

BUY
$10.01 - $13.89 $31,031 - $43,059
3,100 Added 6.42%
51,400 $714,000
Q4 2018

Feb 05, 2019

SELL
$9.15 - $12.26 $43,920 - $58,848
-4,800 Reduced 9.04%
48,300 $527,000
Q3 2018

Nov 07, 2018

SELL
$10.49 - $13.72 $39,862 - $52,136
-3,800 Reduced 6.68%
53,100 $671,000
Q2 2018

Aug 10, 2018

SELL
$10.62 - $13.98 $234,701 - $308,958
-22,100 Reduced 27.97%
56,900 $750,000
Q1 2018

May 08, 2018

BUY
$5.9 - $14.99 $11,210 - $28,481
1,900 Added 2.46%
79,000 $1.08 Million
Q4 2017

Feb 13, 2018

BUY
$5.53 - $8.42 $149,863 - $228,182
27,100 Added 54.2%
77,100 $458,000
Q3 2017

Nov 07, 2017

BUY
$6.5 - $10.69 $54,600 - $89,796
8,400 Added 20.19%
50,000 $371,000
Q2 2017

Nov 20, 2017

BUY
N/A
41,600
41,600 $390,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.